UBI Therapy and Chronic Infection Treatment in Salt Lake City, Utah
UBI therapy in Salt Lake City — ultraviolet blood irradiation — is a clinical therapy with a documented history stretching back to the 1920s, when it was first used to treat systemic bacterial infections. At Clear Health Centers, it occupies a specific and well-defined role in the treatment of chronic infections and immune dysregulation, applied within a comprehensive naturopathic framework and grounded in the available clinical literature.
Chronic infection treatment in Salt Lake City addresses a category of conditions that conventional medicine often underserves: infections that persist in a low-grade state, that don’t resolve fully despite treatment, or that continue to suppress immune function and drive systemic symptoms long after the acute phase. Viral persistence, chronic bacterial burden, and immune dysregulation are areas where UBI therapy has historically shown clinical utility.
How Ultraviolet Blood Irradiation Works
Ultraviolet blood irradiation therapy involves withdrawing a small volume of the patient’s blood, exposing it to ultraviolet light in a controlled medical device, and returning it to the patient intravenously. The process takes approximately 45 to 60 minutes and is performed in a clinical setting.
The mechanism of action is multi-layered. UV light exposure inactivates bacteria, viruses, and fungi directly at the concentrations present in the irradiated blood volume. The irradiated blood, when returned to circulation, acts as an autogenous vaccine, stimulating immune recognition of the inactivated pathogens. Beyond direct antimicrobial effects, UBI therapy modulates cytokine production, increases oxygen utilization in tissues, and stimulates immune cell populations that may be suppressed in chronic infection states.
The therapy does not require large volumes of blood. The immune-modulating effects appear to arise from the signal generated by the irradiated return rather than from the direct treatment of the total blood volume.
Chronic Infections UBI Therapy Addresses
| Infection / Condition | Relevance to UBI Therapy |
| Epstein-Barr Virus (EBV) reactivation | One of the most common applications; persistent EBV reactivation drives chronic fatigue and immune suppression |
| Cytomegalovirus (CMV) chronic infection | CMV persistence impairs immune surveillance; UBI has documented immune-modulatory effects in CMV states |
| Tick-borne illness (Lyme and co-infections) | Used as an adjunct in chronic tick-borne illness protocols where conventional antibiotics have been insufficient |
| Chronic bacterial infections | Low-grade bacterial burden, including recurrent sinus, respiratory, or gut infections with immune suppression |
| Post-viral immune dysregulation | Long COVID and other post-viral states involving sustained immune activation or suppression |
| Chronic viral infection | Persistent viral states where immune exhaustion has prevented complete clearance |
UBI Therapy as Part of a Broader Infection Protocol
UBI therapy is most effective when integrated into a comprehensive approach to chronic infection, rather than used as a standalone treatment. At Clear Health Centers, the therapy is combined with targeted antiviral or antimicrobial support, immune regulation strategies, nutritional optimization, and where relevant, gut health restoration.
Many patients with chronic infections carry co-existing burdens: mold toxin exposure, gut dysbiosis, nutritional deficiencies, or hormonal dysregulation that suppress immune function independently. Addressing these factors alongside UBI therapy produces better outcomes than UBI alone.
Lab assessment before and during a UBI protocol tracks immune markers, inflammatory burden, and pathogen-specific indicators. This provides both a baseline and ongoing evidence of clinical response, allowing the protocol to be adjusted as the patient’s immune status evolves.
The Process at Clear Health Centers
Step 1: Consultation and history. Dr. Haskell reviews infection history, prior treatment, current symptoms, immune lab markers, and co-existing conditions.
Step 2: Lab assessment. Relevant markers including immune panels, viral titers, inflammatory markers, and nutritional status are assessed before the protocol begins.
Step 3: UBI sessions. Blood is drawn, UV-irradiated, and returned intravenously in a monitored clinical setting. Each session takes approximately 45 to 60 minutes.
Step 4: Concurrent support. Antiviral nutrients (high-dose vitamin C, lysine, zinc, selenium, and specific botanicals), immune support, and other indicated therapies are integrated alongside UBI.
Step 5: Reassessment. Immune and infection markers are retested after an initial series to assess response and guide ongoing protocol decisions.
Frequently Asked Questions
Is UBI therapy FDA approved?
UBI devices used clinically are FDA-registered. The therapy itself falls within the scope of clinical practice. It has a clinical history of over 80 years and has been described in peer-reviewed literature. At Clear Health Centers, it is used within a defined clinical framework with appropriate patient selection and monitoring.
Is UBI therapy painful or uncomfortable?
The procedure involves a blood draw and IV return, comparable to a standard blood draw. Most patients find the session comfortable. The irradiation process occurs outside the body and produces no sensation. Some patients report a mild sense of warmth or improved energy during or after the session.
How many UBI sessions are typically needed?
Initial protocols typically involve a series of 6 to 10 sessions administered 1 to 2 times per week. Chronic conditions may require longer series or periodic maintenance sessions. The number is guided by clinical response and reassessed with lab markers at intervals.
Can UBI therapy be used alongside antibiotics or antiviral medications?
Yes. UBI therapy is used as a complement to conventional antimicrobial treatment, not as a replacement. It is particularly useful in cases where conventional treatment has provided incomplete resolution or when ongoing immune support is needed.
Who is not a candidate for UBI therapy?
Patients with porphyria, certain photosensitizing medications, or specific blood disorders may not be appropriate candidates. These are assessed during the initial consultation. UBI therapy is contraindicated during pregnancy. All relevant factors are reviewed before initiating a protocol.
How does UBI therapy differ from ozone therapy?
Both therapies use small amounts of blood and aim to stimulate immune and oxidative pathways, but they operate through different mechanisms. UBI uses ultraviolet light; ozone therapy (major autohemotherapy) uses ozone gas to produce reactive oxygen species. The two therapies are sometimes combined. Dr. Haskell determines the most appropriate protocol for each patient.